Cell separation process

Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424529, 424534, 424561, 435243, 435261, A01N 102, C12N 102

Patent

active

049277502

DESCRIPTION:

BRIEF SUMMARY
TECHNICAL FIELD

This invention relates to a novel composition for the separation and purification of biological cells and subcellular components. In particular, this invention relates to a novel composition for isolating specific cell types or specific subcellular components based upon their buoyant density. In still another aspect, this invention relates to a novel method and means for use in the isolation of specific cell types and specific subcellular components which provides improved purity of recovered cells and subcellular components.


BACKGROUND OF THE INVENTION

Separating components of biological fluids and tissues is often necessary for clinical diagnostic procedures, scientific research, and occasionally treatment of patients. In the clinical diagnostics field, for example, there is a need for compositions and methods which permit rapid isolation of purified lymphocytes for tissue typing procedures, immunologic function tests, and various other procedures. Basic research also requires purified lymphocytes as well as other cell types from blood. In addition, studies on cultured cells and subcellular components such as plasmids, DNA, chromosomes, mitochondria and other subcellular components also require highly purified preparations.
Separation and purification might be effected in several ways. However, since the isolated cells are often used in procedures which require viable cells, it is important that the functions of the cells so isolated be unimpaired. To insure viability of the cells and unimpaired biological function of cells and subcellular components, it is important to avoid introducing possible interfering substances in the course of the separation procedure. For example, isolated lymphocytes used in histocompatibility tests are stimulated with various mitogens. The medium used must not in itself be a mitogen since this will affect the validity of the measurements of DNA synthesis.
Density gradient centrifugation is one technique used for separation of biological cells and subcellular components. It is highly desirable that the material chosen for formation of the gradient have certain characteristics which will impart compatability with sensitive biological materials. Gradient materials which have been employed in the art include sucrose, dextran, bovine serum albumin (BSA), Ficoll (registered trademark of Pharmacia), iodinated low molecular weight compounds such as Metrizamide and heavy salts such as cesium chloride. Most of these materials, however, have undesirable characteristics which potentially may impair the biochemical functions of the desired isolated fractions. For example, some currently available blood separation media contain erythrocyte aggregation polmers which may decrease mitogen responsiveness of isolated lymphocyte preparations (J. Immunol. Meth. 38:43-51, 1980). These materials may also form solutions of undesirably high osmolality or viscosity. Cell aggregation is often caused by BSA at physiological pH (7.4) and it is undesirable to employ reduced pH (5.1) because it introduces other problems such as cell swelling (which alters cell density) and possible impairment of cell function. It is also expensive for use in large scale separations. Ficoll may similarly cause cellular aggregation which can be remedied only by use of a dispersing agent, or undesirably, lowering of the pH. Ficoll is also highly viscous, making it difficult to generate a linear isoosmotic gradient with it. It is also difficult to separate cells with very similar buoyant densities with any of these materials, even with the use of discontinuous gradients.
A density gradient material which has been used with some success for cell separation is colloidal silica. Colloidal silica is an aqueous suspension of colloidal particles formed by polymerization of monosilicic acid from SiO.sub.2 dissolved in water. Individual particles average 130-140 .ANG. in size and generally range from about 30 to 220 .ANG.. The colloidal suspension is most stable for storage at pH 8-10 at which the colloidal particl

REFERENCES:
patent: 3795313 (1974-03-01), Kirkland et al.
patent: 3977982 (1976-08-01), Hertl
patent: 3983299 (1976-09-01), Regnier
patent: 3984349 (1976-10-01), Meiller et al.
patent: 4034072 (1977-07-01), Mjos et al.
patent: 4108603 (1978-08-01), Regnier et al.
patent: 4172803 (1979-10-01), Ichikawa et al.
patent: 4177315 (1979-12-01), Ubersax
patent: 4188451 (1980-02-01), Humphrey, Jr.
patent: 4190535 (1980-02-01), Luderer et al.
patent: 4406792 (1983-09-01), Glad et al.
patent: 4409496 (1977-09-01), Henry
patent: 4415631 (1983-11-01), Schutijser
patent: 4457782 (1984-07-01), Honda et al.
patent: 4480038 (1984-10-01), Cheng
patent: 4487700 (1984-12-01), Kanter
Gollin et al, "Isopycnic Centrifugation of Mammalian Metaphase Chromosomes in Nycodenz," 152 Experimental Cell Research, 204-11 (1984).
Traitler, "A Cold Silanization Method for Preparation of Medium Polarity Capillary Columns," 6 J. of High Resolution Chromatography and Chromatography Comunications 60-63 (1983).
Pertoft et al, "Sedimentation of Cells in Colloidal Silica (percoll)," in Cell Separation: Methods and Selected Applications, vol. I, pp. 115-152 (1982).
Feucht et al, "Efficient Separation of Human T Lymphocytes from Venous Blood Using PVP-Coated Colloidal Silica Particles (Percoll)," J. of Immunological Methods 43-51 (1980).
Lundak et al, "Separation of Functional Subpopulations of Murine and Human Lymphoid Cells on Colloidal Silica Density Gradients I. Preparation of the Ludox AM.RTM. Gradient Material and Characterization of Separation Capacities." 28 J. of Immunological Methods 277-92 (1979).
Pertoft et al., "Density Gradients Prepared from Colloidal Silica Particles Coated by Polyvinyl-Pyrrolidone (Percoll)," 88 Analytical Biochemistry 271-82 (1978).
Pertoft et al, "The Viability of Cells Grown or Centrifuged in a New Density Gradient Medium, Percoll(#)," 110 Experimental Cell Research, 449-57 (1977).
Iler, "The Effect of Surface Aluminosilicate Ions on the Properties of Colloidal Silica," 55 J. of Colloid and Interface Science, 25-34 (1976).
Morgenthaler, "Factors Affecting the Separation of Photosynthetically Competent Chloroplasts in Gradients of Silica Sols," 168 Archives of Biochemistry and Biophysics, 289-301 (1975).
Aiuti et al, "Identification, Enumeration and Isolation of B and T Lymphocytes from Human Peripheral Blood," 3 Clinical Immunology and Immunopathology, 584-97 (1975).
Brown et al, "Enumeration of Absolute Numbers of T and B Lymphocytes in Human Blood," 3 Scandanavian Journal of Immunology, 161-172 (1974).
Iler, "Coacervates of Polyvinyl Alcohol and Colloidal Silica," 51 J. of Colloid and Interface Science, 388-93 (1975).
Pertoft, "The Separation of Rat Liver Cells in Colloidal Silica-Polyethylene Glycol Gradients," 57 Experimental Cell Research 338-50 (1969).
Wolff et al, "Separation of HeLa Cells by Colloidal Silica Density Gradients Centrifugation," 55 J. of Cell Biology 579-85 (1972).
Pertoft et al, "Separation of Various Blood Cells in Colloidal Silica-Polyvinyl Pyrrolodine Gradients," 50 Experimental Cell Research 355-68 (1968).
Pertoft, "Separation of Blood Cells Using Colloidal Silica-Polysaccharide Gradients," 46 Experimental Cell Research 621-23 (1966).
Schmidt et al, "Fractionation of Cell Organelles in Silica Cell Gradients," Methods in Cell Biology, vol. XV, pp. 177-201 (1977).
Pertoft et al, "Isopycnic Separation of Cells and Cell Organelles by Centrifugation and Modified Colloidal Silica Gradients" in Methods of Cell Separation, vol. I, pp. 25-65 (1977).
Pretlow et al, "Problems Connected with the Separation of Different Kinds of Cells," 14 International Review of Experimental Pathology 92-204 (1975).
Shortman, "Physical Procedures for the Separation of Animal Cells", 1 Annual Reviews of Biophysics and Engineering 93-130 (1972).
Pharmacia Fine Chemicals, "Percoll.RTM. Methodology and Applications" (1982).
Pharmacia Fine Chemicals, "Ficoll-Paque.RTM. for In Vitro Isolation of Lymphocytes," (1983).
"Ludox.RTM. Colloidal Silica".
Gallard-Schlesinger Che

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cell separation process does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell separation process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell separation process will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2134428

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.